Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 3 TO FORM S-1 - Pulse Biosciences, Inc. | d11949ds1a.htm |
| EX-1.1 - EX-1.1 - Pulse Biosciences, Inc. | d11949dex11.htm |
| EX-5.1 - EX-5.1 - Pulse Biosciences, Inc. | d11949dex51.htm |
| EX-23.1 - EX-23.1 - Pulse Biosciences, Inc. | d11949dex231.htm |
| EX-23.2 - EX-23.2 - Pulse Biosciences, Inc. | d11949dex232.htm |
| EX-10.14 - EX-10.14 - Pulse Biosciences, Inc. | d11949dex1014.htm |
| EX-10.15 - EX-10.15 - Pulse Biosciences, Inc. | d11949dex1015.htm |
| EX-10.12 - EX-10.12 - Pulse Biosciences, Inc. | d11949dex1012.htm |
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Pulse Biosciences, Inc.
We hereby consent to the use in the Prospectus constituting a part of this pre-effective amendment number 3 to Form S-1 Registration Statement (registration number 333-208694) of our report dated December 21, 2015, relating to the balance sheets of ThelioPulse, Inc. (the “Company”) as of December 31, 2013 and 2012, and the related statements of operations, stockholders’ deficiency, and cash flows for the year ended December 31, 2013 and for the period from January 5, 2012 (inception) through December 31, 2012, which is contained in the Prospectus. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ Gumbiner Savett Inc.
May 3, 2016
Santa Monica, California